BriaCell Therapeutics Corp. (TSE:BCT – Get Free Report) shares were up 6.4% during mid-day trading on Thursday. The stock traded as high as C$6.20 and last traded at C$6.02. 12,047 shares traded hands during mid-day trading, a decline of 27% from the average daily volume of 16,530 shares. The stock had previously closed at C$5.66.
BriaCell Therapeutics Stock Performance
The stock has a market capitalization of C$52.55 million, a P/E ratio of -7.19 and a beta of 2.26. The business has a fifty day simple moving average of C$5.12 and a 200-day simple moving average of C$5.15.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and improve patients’ lives. Immunotherapies have become the forefront of the fight against cancer because they use the body’s immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence.
Featured Stories
- Five stocks we like better than BriaCell Therapeutics
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
- Best Buy Is Turning Amazon Fire TV Into a New Advertising Opportunity
- MarketBeat Week in Review – 09/21 – 09/25
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
